Status:
COMPLETED
Co-designing Personalised Assistive Technology
Lead Sponsor:
Swansea University
Collaborating Sponsors:
Swansea Bay University Health Board
Conditions:
Disability or Chronic Disease Leading to Disablement
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Assistive technology is an important tool in helping people maintain independence, allowing them to actively participate in education, work, and society. If maximised to its full potential there would...
Detailed Description
PROCEDURE: 1. Referral: Potential participants will be identified by a healthcare professional from their current care team and asked whether they would like to participate in the study. Potential pa...
Eligibility Criteria
Inclusion
- Confirmed diagnosis of a long-term chronic condition
- Living in the community
- Age eighteen years or older
- Ability to actively engage in a co-design process, as determined by the referring clinician, including:
- Sufficient comprehension of language to engage in meaningful verbal dialogue with the researcher.
- Sufficient insight into their condition such that they understand their needs.
- Sufficient ability to communicate their needs.
- Sufficient ability to retain information between sessions
- Currently under the care of healthcare services within Swansea Bay University Health Board
- At least three-month post injury/diagnosis at the point of recruitment allowing time for spontaneous recovery and for the person to become aware of their difficulties and the implications of this on their lives
Exclusion
- Receptive or expressive language difficulties, or extremely low memory function that may preclude people from engaging meaningfully
- Medically unstable, severe mental health or cognitive difficulties which may preclude meaningful engagement in the study.
- Not able to provide informed consent.
- Have insufficient access to the internet to engage virtually with the researcher through video conferencing software.
Key Trial Info
Start Date :
May 10 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2022
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT04836624
Start Date
May 10 2021
End Date
September 30 2022
Last Update
April 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Swansea Bay University Health Board
Swansea, United Kingdom, SA6 6NL